These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 578756

  • 1. [On the pharmacokinetics of phenazone in man (author's transl)].
    Brinkmann HJ, Hengstmann JH, Müller F.
    Arzneimittelforschung; 1977; 27(8):1609-12. PubMed ID: 578756
    [Abstract] [Full Text] [Related]

  • 2. [Comparative pharmacokinetics of paracetamol in humans following single oral and rectal administration (author's transl)].
    Liedtke R, Berner G, Haase W, Nicolai W, Staab R, Wagener HH.
    Arzneimittelforschung; 1979; 29(10):1607-11. PubMed ID: 583229
    [Abstract] [Full Text] [Related]

  • 3. [On the metabolism of antipyrine (phenazone) in man (author's transl)].
    Zietz E, Eichelbaum M, Dengler HJ, Spiteller G.
    Arzneimittelforschung; 1978; 28(2):315-9. PubMed ID: 580401
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M, Ochs HR, Roberts G, Somogyi A.
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [Abstract] [Full Text] [Related]

  • 5. [Multiple-dose pharmacokinetics of paracetamol and salicylamide in man after combined rectal application (author's transl)].
    Liedtke R, Ebel S, Missler B, Haase W, Stein L.
    Arzneimittelforschung; 1980; 30(8):1295-8. PubMed ID: 7192145
    [Abstract] [Full Text] [Related]

  • 6. [Changes in drug elimination under the influence of perazine therapy (author's transl)].
    Petruch F, Schüppel R, Breyer U.
    Arzneimittelforschung; 1976; 26(6):1154-5. PubMed ID: 9113
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bioavailability of allopurinol oral and rectal dosage forms.
    Chang SL, Kramer WG, Feldman S, Ballentine R, Frankel LS.
    Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W, Barth H, Osterloh G, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [Abstract] [Full Text] [Related]

  • 15. Absorption and elimination of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): comparison between young and elderly subjects.
    Melander A, Bodin NO, Danielson K, Gustafsson B, Haglund G, Westerlund D.
    Acta Med Scand; 1978 Sep; 203(1-2):121-4. PubMed ID: 626106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
    Maier-Lenz H, Ringwelski L, Windorfer A.
    Arzneimittelforschung; 1981 Sep; 31(1):105-9. PubMed ID: 7194086
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.
    Bässmann H, Böttcher J, Schüppel R.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):203-5. PubMed ID: 522906
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.